Company: INDP
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001641172-25-014972
Chunk: 5

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item       Financial                 

(d)
Exhibits.

  Exhibit      Description                                                                                                                                 
      No.                                                                                                                                                  
     10.1      Form of Securities Purchase Agreement, dated as of June 12, 2025, between the Company and the investors signatory thereto                   
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.2      Form of Convertible Promissory Note                                                                                                         
     10.3      Form of Common Warrant                                                                                                                      
     10.4      Form of Placement Agent Agreement, dated as of May 9, 2025, by and between Indaptus Therapeutics, Inc. and Paulson Investment Company, LLC  
     99.1      Press                                                                                                                                       
      104      Cover                                                                                                                                       

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
June 13,2025